1. The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus
    Jie Qian et al, 2021, Frontiers in Oncology CrossRef
  2. A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease
    James A Timmons et al, 2022, eLife CrossRef
  3. The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review
    Alessia Belloni et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
  4. Cellular Origins of EGFR‚ÄźDriven Lung Cancer Cells Determine Sensitivity to Therapy
    Fan Chen et al, 2021, Advanced Science CrossRef
  5. Obesity: a perfect storm for carcinogenesis
    Benjamin H. L. Harris et al, 2022, Cancer and Metastasis Reviews CrossRef